5th May 2016
Mercia has committed follow-on capital to Medherant Ltd. Medherant’s patch, known as the TEPI-patch®, is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs.
Press Releases
22nd February 2016
Researchers at the University of Warwick have worked with Coventry-based Medherant, a Warwick spinout company, to produce and patent the World’s first ever ibuprofen patch deli
General News
22nd February 2016
Ibuprofen Patch Heralds Side Effect Free Drug Future
General News
1st February 2016
As universities have become better at organising their theoretical research into commercial propositions, intermediaries have appeared on the scene to nurture their research until it is ready to be commercialised.
General News
2nd November 2015
We had over 30 very encouraging partnering meetings with companies who could be potential investors or development partners
General News
8th June 2015
New bio-adhesive company Medherant, founded by Warwick Ventures for the University of Warwick, UK, in 2014, has signed a license agreement with the leading global adhesive specialists Bostik.
General News

Pages